One Third of Architects Use Virtual Reality Now. How Is It Changing Our Buildings and Homes?

Architects are increasingly turning toward virtual reality (VR) to help them with their designs. No matter how good a blueprint or sketch may be, there is nothing like seeing your design or the property in 3D. A space can look bigger or smaller in 2D than it really is, while a 3D rendering will provide the architect, engineer, or designer with a more accurate conception of what they are working with.

This is a powerful tool not only for architects and designers, but also for their clients, who can “walk in” and see what it will look like when finished. This can go so far as to include avatars which represent architects or contractors.

There are also augmented reality (AR) and mixed reality (MR), which allows people to see objects that are not actually in the room as though they are tangible. Many people are perhaps familiar with this concept from the game Pokemon Go, and the more recent Jurassic World Alive. It may be a little less splashy than seeing a Tyrannosaurus Rex walking across a lawn in such a way as to look real, but it is much more practical to see what the change in a kitchen design will actually look like, or to see how the light will reflect off of certain surfaces.

All of this is no doubt why 35 percent of architects use VR, AR, or MR and 79 percent expect these technologies will make their work more efficient. There seems little doubt the future of architecture, engineering, and design lies in the continued use of these technologies that make the work itself easier and improves the ability of firms and customers alike to create what the customer wants.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More